nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—HTR7—coronary artery disease	0.103	0.325	CbGaD
Mirtazapine—ADRB1—coronary artery disease	0.0886	0.278	CbGaD
Mirtazapine—ADRB2—coronary artery disease	0.0745	0.234	CbGaD
Mirtazapine—HTR2A—coronary artery disease	0.052	0.163	CbGaD
Mirtazapine—ADRB2—Penbutolol—coronary artery disease	0.0276	0.074	CbGbCtD
Mirtazapine—ADRB1—Penbutolol—coronary artery disease	0.0272	0.0729	CbGbCtD
Mirtazapine—HTR1A—Penbutolol—coronary artery disease	0.0218	0.0583	CbGbCtD
Mirtazapine—ADRB2—Timolol—coronary artery disease	0.0194	0.0521	CbGbCtD
Mirtazapine—ADRB1—Timolol—coronary artery disease	0.0191	0.0513	CbGbCtD
Mirtazapine—CYP2C8—Fenofibrate—coronary artery disease	0.0157	0.042	CbGbCtD
Mirtazapine—CYP2C8—Gemfibrozil—coronary artery disease	0.0125	0.0335	CbGbCtD
Mirtazapine—CYP2C9—Fenofibrate—coronary artery disease	0.0109	0.0293	CbGbCtD
Mirtazapine—CYP2C8—Clopidogrel—coronary artery disease	0.0109	0.0291	CbGbCtD
Mirtazapine—CYP1A2—Gemfibrozil—coronary artery disease	0.00969	0.026	CbGbCtD
Mirtazapine—CYP2C8—Pitavastatin—coronary artery disease	0.00948	0.0254	CbGbCtD
Mirtazapine—CYP2C9—Gemfibrozil—coronary artery disease	0.00873	0.0234	CbGbCtD
Mirtazapine—CYP1A2—Clopidogrel—coronary artery disease	0.0084	0.0225	CbGbCtD
Mirtazapine—CYP2C9—Clopidogrel—coronary artery disease	0.00757	0.0203	CbGbCtD
Mirtazapine—CYP3A4—Ticagrelor—coronary artery disease	0.00712	0.0191	CbGbCtD
Mirtazapine—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00681	0.0183	CbGbCtD
Mirtazapine—CYP2C9—Pitavastatin—coronary artery disease	0.00661	0.0177	CbGbCtD
Mirtazapine—CYP2C8—Simvastatin—coronary artery disease	0.0065	0.0174	CbGbCtD
Mirtazapine—CYP2C9—Valsartan—coronary artery disease	0.00643	0.0172	CbGbCtD
Mirtazapine—CYP2C8—Pravastatin—coronary artery disease	0.00636	0.0171	CbGbCtD
Mirtazapine—CYP2C8—Lovastatin—coronary artery disease	0.00636	0.0171	CbGbCtD
Mirtazapine—CYP3A4—Fenofibrate—coronary artery disease	0.00635	0.017	CbGbCtD
Mirtazapine—CYP2C8—Atorvastatin—coronary artery disease	0.00579	0.0155	CbGbCtD
Mirtazapine—HTR2B—cardial valve—coronary artery disease	0.00549	0.13	CbGeAlD
Mirtazapine—CYP2C8—Losartan—coronary artery disease	0.0053	0.0142	CbGbCtD
Mirtazapine—CYP2D6—Niacin—coronary artery disease	0.00524	0.0141	CbGbCtD
Mirtazapine—CYP3A4—Gemfibrozil—coronary artery disease	0.00508	0.0136	CbGbCtD
Mirtazapine—CYP2C9—Rosuvastatin—coronary artery disease	0.00488	0.0131	CbGbCtD
Mirtazapine—CYP2D6—Timolol—coronary artery disease	0.00488	0.0131	CbGbCtD
Mirtazapine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00475	0.0127	CbGbCtD
Mirtazapine—CYP2C9—Simvastatin—coronary artery disease	0.00453	0.0122	CbGbCtD
Mirtazapine—CYP2C9—Pravastatin—coronary artery disease	0.00444	0.0119	CbGbCtD
Mirtazapine—CYP2C9—Lovastatin—coronary artery disease	0.00444	0.0119	CbGbCtD
Mirtazapine—CYP3A4—Clopidogrel—coronary artery disease	0.0044	0.0118	CbGbCtD
Mirtazapine—CYP2D6—Captopril—coronary artery disease	0.00429	0.0115	CbGbCtD
Mirtazapine—CYP2D6—Simvastatin—coronary artery disease	0.00415	0.0111	CbGbCtD
Mirtazapine—CYP1A2—Losartan—coronary artery disease	0.0041	0.011	CbGbCtD
Mirtazapine—CYP3A4—Eplerenone—coronary artery disease	0.00409	0.011	CbGbCtD
Mirtazapine—CYP2D6—Pravastatin—coronary artery disease	0.00406	0.0109	CbGbCtD
Mirtazapine—CYP2D6—Lovastatin—coronary artery disease	0.00406	0.0109	CbGbCtD
Mirtazapine—CYP2C9—Atorvastatin—coronary artery disease	0.00404	0.0108	CbGbCtD
Mirtazapine—CYP2C9—Losartan—coronary artery disease	0.0037	0.00991	CbGbCtD
Mirtazapine—CYP2D6—Atorvastatin—coronary artery disease	0.0037	0.00991	CbGbCtD
Mirtazapine—CYP3A4—Enalapril—coronary artery disease	0.00365	0.00977	CbGbCtD
Mirtazapine—CYP2C9—cardial valve—coronary artery disease	0.00356	0.084	CbGeAlD
Mirtazapine—CYP3A4—Rosuvastatin—coronary artery disease	0.00284	0.0076	CbGbCtD
Mirtazapine—CYP3A4—Ezetimibe—coronary artery disease	0.00284	0.0076	CbGbCtD
Mirtazapine—HTR3A—vagus nerve—coronary artery disease	0.00277	0.0654	CbGeAlD
Mirtazapine—CYP3A4—Simvastatin—coronary artery disease	0.00264	0.00707	CbGbCtD
Mirtazapine—CYP3A4—Lovastatin—coronary artery disease	0.00258	0.00692	CbGbCtD
Mirtazapine—CYP3A4—Pravastatin—coronary artery disease	0.00258	0.00692	CbGbCtD
Mirtazapine—CYP3A4—Atorvastatin—coronary artery disease	0.00235	0.0063	CbGbCtD
Mirtazapine—CYP3A4—Losartan—coronary artery disease	0.00215	0.00576	CbGbCtD
Mirtazapine—SLC6A2—sympathetic nervous system—coronary artery disease	0.00192	0.0453	CbGeAlD
Mirtazapine—HTR7—pulmonary artery—coronary artery disease	0.0019	0.0449	CbGeAlD
Mirtazapine—HTR7—sympathetic nervous system—coronary artery disease	0.00185	0.0437	CbGeAlD
Mirtazapine—HTR2A—arteriole—coronary artery disease	0.00181	0.0427	CbGeAlD
Mirtazapine—HTR7—vagus nerve—coronary artery disease	0.00179	0.0423	CbGeAlD
Mirtazapine—HTR7—vein—coronary artery disease	0.00173	0.0409	CbGeAlD
Mirtazapine—SLC6A2—autonomic nervous system—coronary artery disease	0.00129	0.0305	CbGeAlD
Mirtazapine—HTR7—autonomic nervous system—coronary artery disease	0.00124	0.0294	CbGeAlD
Mirtazapine—HTR2A—pulmonary artery—coronary artery disease	0.00119	0.028	CbGeAlD
Mirtazapine—HTR2A—sympathetic nervous system—coronary artery disease	0.00115	0.0272	CbGeAlD
Mirtazapine—HTR2A—vagus nerve—coronary artery disease	0.00112	0.0264	CbGeAlD
Mirtazapine—HTR2A—vein—coronary artery disease	0.00108	0.0255	CbGeAlD
Mirtazapine—DRD4—heart—coronary artery disease	0.000826	0.0195	CbGeAlD
Mirtazapine—Epinastine—HRH2—coronary artery disease	0.000793	0.419	CrCbGaD
Mirtazapine—HTR2A—autonomic nervous system—coronary artery disease	0.000776	0.0183	CbGeAlD
Mirtazapine—HTR7—artery—coronary artery disease	0.000706	0.0166	CbGeAlD
Mirtazapine—HRH3—blood—coronary artery disease	0.000625	0.0148	CbGeAlD
Mirtazapine—HTR7—endothelium—coronary artery disease	0.000596	0.0141	CbGeAlD
Mirtazapine—ADRB1—cardiac ventricle—coronary artery disease	0.000483	0.0114	CbGeAlD
Mirtazapine—Mianserin—HRH2—coronary artery disease	0.000459	0.243	CrCbGaD
Mirtazapine—ADRB1—myocardium—coronary artery disease	0.000454	0.0107	CbGeAlD
Mirtazapine—HTR2A—artery—coronary artery disease	0.00044	0.0104	CbGeAlD
Mirtazapine—HTR2A—endothelium—coronary artery disease	0.000372	0.00877	CbGeAlD
Mirtazapine—ADRA2C—cardiac ventricle—coronary artery disease	0.000364	0.00858	CbGeAlD
Mirtazapine—ADRA2C—myocardium—coronary artery disease	0.000342	0.00807	CbGeAlD
Mirtazapine—ADRB1—heart—coronary artery disease	0.000317	0.00748	CbGeAlD
Mirtazapine—HTR2B—heart—coronary artery disease	0.000304	0.00716	CbGeAlD
Mirtazapine—HTR3A—blood—coronary artery disease	0.0003	0.00707	CbGeAlD
Mirtazapine—ADRB1—cardiovascular system—coronary artery disease	0.000299	0.00706	CbGeAlD
Mirtazapine—HTR2B—cardiovascular system—coronary artery disease	0.000286	0.00676	CbGeAlD
Mirtazapine—ADRB1—cardiac atrium—coronary artery disease	0.000271	0.0064	CbGeAlD
Mirtazapine—Epinastine—HTR7—coronary artery disease	0.00027	0.143	CrCbGaD
Mirtazapine—HTR7—heart—coronary artery disease	0.00026	0.00613	CbGeAlD
Mirtazapine—HTR1A—cardiovascular system—coronary artery disease	0.000257	0.00605	CbGeAlD
Mirtazapine—ADRA1A—heart—coronary artery disease	0.000251	0.00591	CbGeAlD
Mirtazapine—HTR7—cardiovascular system—coronary artery disease	0.000245	0.00579	CbGeAlD
Mirtazapine—ADRA2C—heart—coronary artery disease	0.000239	0.00564	CbGeAlD
Mirtazapine—ADRA1A—cardiovascular system—coronary artery disease	0.000237	0.00558	CbGeAlD
Mirtazapine—SLC6A4—blood—coronary artery disease	0.000229	0.00539	CbGeAlD
Mirtazapine—HTR2B—blood—coronary artery disease	0.000226	0.00534	CbGeAlD
Mirtazapine—ADRA2C—cardiac atrium—coronary artery disease	0.000204	0.00482	CbGeAlD
Mirtazapine—CYP2C9—heart—coronary artery disease	0.000197	0.00464	CbGeAlD
Mirtazapine—HTR7—blood—coronary artery disease	0.000194	0.00458	CbGeAlD
Mirtazapine—ADRA2A—heart—coronary artery disease	0.000191	0.0045	CbGeAlD
Mirtazapine—ADRA1A—blood—coronary artery disease	0.000187	0.00441	CbGeAlD
Mirtazapine—CYP2C9—cardiovascular system—coronary artery disease	0.000186	0.00438	CbGeAlD
Mirtazapine—ADRA2C—blood—coronary artery disease	0.000178	0.00421	CbGeAlD
Mirtazapine—CYP2C8—blood—coronary artery disease	0.000165	0.0039	CbGeAlD
Mirtazapine—ADRA2A—cardiac atrium—coronary artery disease	0.000163	0.00385	CbGeAlD
Mirtazapine—HTR2A—heart—coronary artery disease	0.000162	0.00382	CbGeAlD
Mirtazapine—Mianserin—HTR7—coronary artery disease	0.000156	0.0825	CrCbGaD
Mirtazapine—CYP1A2—blood—coronary artery disease	0.000155	0.00365	CbGeAlD
Mirtazapine—HTR2A—cardiovascular system—coronary artery disease	0.000153	0.00361	CbGeAlD
Mirtazapine—CYP2C9—blood—coronary artery disease	0.000147	0.00346	CbGeAlD
Mirtazapine—ADRA2A—blood—coronary artery disease	0.000142	0.00336	CbGeAlD
Mirtazapine—Epinastine—HTR2A—coronary artery disease	0.000136	0.0717	CrCbGaD
Mirtazapine—HTR2A—blood—coronary artery disease	0.000121	0.00285	CbGeAlD
Mirtazapine—CYP3A4—blood—coronary artery disease	0.000112	0.00264	CbGeAlD
Mirtazapine—CYP2D6—blood—coronary artery disease	0.00011	0.0026	CbGeAlD
Mirtazapine—Mianserin—HTR2A—coronary artery disease	7.84e-05	0.0415	CrCbGaD
Mirtazapine—Asthenia—Niacin—coronary artery disease	3.15e-05	0.000198	CcSEcCtD
Mirtazapine—Fatigue—Losartan—coronary artery disease	3.15e-05	0.000198	CcSEcCtD
Mirtazapine—Headache—Ezetimibe—coronary artery disease	3.14e-05	0.000197	CcSEcCtD
Mirtazapine—Malaise—Lisinopril—coronary artery disease	3.14e-05	0.000197	CcSEcCtD
Mirtazapine—Oedema—Ramipril—coronary artery disease	3.13e-05	0.000197	CcSEcCtD
Mirtazapine—Vertigo—Lisinopril—coronary artery disease	3.13e-05	0.000196	CcSEcCtD
Mirtazapine—Dry mouth—Timolol—coronary artery disease	3.12e-05	0.000196	CcSEcCtD
Mirtazapine—Pain—Losartan—coronary artery disease	3.12e-05	0.000196	CcSEcCtD
Mirtazapine—Constipation—Losartan—coronary artery disease	3.12e-05	0.000196	CcSEcCtD
Mirtazapine—Syncope—Lisinopril—coronary artery disease	3.12e-05	0.000196	CcSEcCtD
Mirtazapine—Vomiting—Eplerenone—coronary artery disease	3.12e-05	0.000196	CcSEcCtD
Mirtazapine—Feeling abnormal—Furosemide—coronary artery disease	3.12e-05	0.000196	CcSEcCtD
Mirtazapine—Leukopenia—Lisinopril—coronary artery disease	3.12e-05	0.000195	CcSEcCtD
Mirtazapine—Nausea—Fenofibrate—coronary artery disease	3.11e-05	0.000195	CcSEcCtD
Mirtazapine—Pruritus—Niacin—coronary artery disease	3.11e-05	0.000195	CcSEcCtD
Mirtazapine—Asthenia—Pravastatin—coronary artery disease	3.1e-05	0.000195	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Furosemide—coronary artery disease	3.1e-05	0.000194	CcSEcCtD
Mirtazapine—Rash—Eplerenone—coronary artery disease	3.1e-05	0.000194	CcSEcCtD
Mirtazapine—Urticaria—Perindopril—coronary artery disease	3.09e-05	0.000194	CcSEcCtD
Mirtazapine—Hypersensitivity—Trandolapril—coronary artery disease	3.09e-05	0.000194	CcSEcCtD
Mirtazapine—Dermatitis—Eplerenone—coronary artery disease	3.09e-05	0.000194	CcSEcCtD
Mirtazapine—Diarrhoea—Valsartan—coronary artery disease	3.09e-05	0.000194	CcSEcCtD
Mirtazapine—Confusional state—Timolol—coronary artery disease	3.09e-05	0.000194	CcSEcCtD
Mirtazapine—Shock—Ramipril—coronary artery disease	3.08e-05	0.000193	CcSEcCtD
Mirtazapine—Hypersensitivity—Enalapril—coronary artery disease	3.08e-05	0.000193	CcSEcCtD
Mirtazapine—Body temperature increased—Perindopril—coronary artery disease	3.08e-05	0.000193	CcSEcCtD
Mirtazapine—Abdominal pain—Perindopril—coronary artery disease	3.08e-05	0.000193	CcSEcCtD
Mirtazapine—Palpitations—Lisinopril—coronary artery disease	3.08e-05	0.000193	CcSEcCtD
Mirtazapine—Diarrhoea—Olmesartan—coronary artery disease	3.08e-05	0.000193	CcSEcCtD
Mirtazapine—Headache—Eplerenone—coronary artery disease	3.08e-05	0.000193	CcSEcCtD
Mirtazapine—Nervous system disorder—Ramipril—coronary artery disease	3.07e-05	0.000193	CcSEcCtD
Mirtazapine—Thrombocytopenia—Ramipril—coronary artery disease	3.07e-05	0.000192	CcSEcCtD
Mirtazapine—Oedema—Timolol—coronary artery disease	3.06e-05	0.000192	CcSEcCtD
Mirtazapine—Pruritus—Pravastatin—coronary artery disease	3.06e-05	0.000192	CcSEcCtD
Mirtazapine—Loss of consciousness—Lisinopril—coronary artery disease	3.06e-05	0.000192	CcSEcCtD
Mirtazapine—Nausea—Clopidogrel—coronary artery disease	3.06e-05	0.000192	CcSEcCtD
Mirtazapine—Tachycardia—Ramipril—coronary artery disease	3.06e-05	0.000192	CcSEcCtD
Mirtazapine—Skin disorder—Ramipril—coronary artery disease	3.04e-05	0.000191	CcSEcCtD
Mirtazapine—Infection—Timolol—coronary artery disease	3.04e-05	0.000191	CcSEcCtD
Mirtazapine—Vomiting—Simvastatin—coronary artery disease	3.04e-05	0.000191	CcSEcCtD
Mirtazapine—Hypersensitivity—Telmisartan—coronary artery disease	3.04e-05	0.000191	CcSEcCtD
Mirtazapine—Cough—Lisinopril—coronary artery disease	3.04e-05	0.000191	CcSEcCtD
Mirtazapine—Nausea—Lovastatin—coronary artery disease	3.04e-05	0.000191	CcSEcCtD
Mirtazapine—Hyperhidrosis—Ramipril—coronary artery disease	3.03e-05	0.00019	CcSEcCtD
Mirtazapine—Rash—Simvastatin—coronary artery disease	3.02e-05	0.000189	CcSEcCtD
Mirtazapine—Dermatitis—Simvastatin—coronary artery disease	3.01e-05	0.000189	CcSEcCtD
Mirtazapine—Asthenia—Trandolapril—coronary artery disease	3.01e-05	0.000189	CcSEcCtD
Mirtazapine—Shock—Timolol—coronary artery disease	3.01e-05	0.000189	CcSEcCtD
Mirtazapine—Feeling abnormal—Losartan—coronary artery disease	3.01e-05	0.000189	CcSEcCtD
Mirtazapine—Urticaria—Furosemide—coronary artery disease	3.01e-05	0.000189	CcSEcCtD
Mirtazapine—Diarrhoea—Niacin—coronary artery disease	3.01e-05	0.000189	CcSEcCtD
Mirtazapine—Nervous system disorder—Timolol—coronary artery disease	3e-05	0.000188	CcSEcCtD
Mirtazapine—Asthenia—Enalapril—coronary artery disease	3e-05	0.000188	CcSEcCtD
Mirtazapine—Headache—Simvastatin—coronary artery disease	3e-05	0.000188	CcSEcCtD
Mirtazapine—Body temperature increased—Furosemide—coronary artery disease	2.99e-05	0.000188	CcSEcCtD
Mirtazapine—Abdominal pain—Furosemide—coronary artery disease	2.99e-05	0.000188	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Losartan—coronary artery disease	2.99e-05	0.000187	CcSEcCtD
Mirtazapine—Dizziness—Valsartan—coronary artery disease	2.99e-05	0.000187	CcSEcCtD
Mirtazapine—Anorexia—Ramipril—coronary artery disease	2.99e-05	0.000187	CcSEcCtD
Mirtazapine—Nausea—Ezetimibe—coronary artery disease	2.98e-05	0.000187	CcSEcCtD
Mirtazapine—Skin disorder—Timolol—coronary artery disease	2.98e-05	0.000187	CcSEcCtD
Mirtazapine—Dizziness—Olmesartan—coronary artery disease	2.97e-05	0.000186	CcSEcCtD
Mirtazapine—Pruritus—Trandolapril—coronary artery disease	2.97e-05	0.000186	CcSEcCtD
Mirtazapine—Arthralgia—Lisinopril—coronary artery disease	2.96e-05	0.000186	CcSEcCtD
Mirtazapine—Myalgia—Lisinopril—coronary artery disease	2.96e-05	0.000186	CcSEcCtD
Mirtazapine—Chest pain—Lisinopril—coronary artery disease	2.96e-05	0.000186	CcSEcCtD
Mirtazapine—Hyperhidrosis—Timolol—coronary artery disease	2.96e-05	0.000186	CcSEcCtD
Mirtazapine—Asthenia—Telmisartan—coronary artery disease	2.96e-05	0.000186	CcSEcCtD
Mirtazapine—Pruritus—Enalapril—coronary artery disease	2.96e-05	0.000186	CcSEcCtD
Mirtazapine—Diarrhoea—Pravastatin—coronary artery disease	2.96e-05	0.000186	CcSEcCtD
Mirtazapine—Anxiety—Lisinopril—coronary artery disease	2.95e-05	0.000185	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.94e-05	0.000185	CcSEcCtD
Mirtazapine—Discomfort—Lisinopril—coronary artery disease	2.93e-05	0.000184	CcSEcCtD
Mirtazapine—Hypotension—Ramipril—coronary artery disease	2.93e-05	0.000184	CcSEcCtD
Mirtazapine—Anorexia—Timolol—coronary artery disease	2.92e-05	0.000183	CcSEcCtD
Mirtazapine—Pruritus—Telmisartan—coronary artery disease	2.92e-05	0.000183	CcSEcCtD
Mirtazapine—Nausea—Eplerenone—coronary artery disease	2.92e-05	0.000183	CcSEcCtD
Mirtazapine—Dizziness—Niacin—coronary artery disease	2.9e-05	0.000182	CcSEcCtD
Mirtazapine—Urticaria—Losartan—coronary artery disease	2.9e-05	0.000182	CcSEcCtD
Mirtazapine—Dry mouth—Lisinopril—coronary artery disease	2.9e-05	0.000182	CcSEcCtD
Mirtazapine—Abdominal pain—Losartan—coronary artery disease	2.89e-05	0.000181	CcSEcCtD
Mirtazapine—Body temperature increased—Losartan—coronary artery disease	2.89e-05	0.000181	CcSEcCtD
Mirtazapine—Asthenia—Captopril—coronary artery disease	2.88e-05	0.000181	CcSEcCtD
Mirtazapine—Diarrhoea—Trandolapril—coronary artery disease	2.87e-05	0.00018	CcSEcCtD
Mirtazapine—Vomiting—Valsartan—coronary artery disease	2.87e-05	0.00018	CcSEcCtD
Mirtazapine—Confusional state—Lisinopril—coronary artery disease	2.87e-05	0.00018	CcSEcCtD
Mirtazapine—Diarrhoea—Enalapril—coronary artery disease	2.86e-05	0.00018	CcSEcCtD
Mirtazapine—Hypotension—Timolol—coronary artery disease	2.86e-05	0.00018	CcSEcCtD
Mirtazapine—Dizziness—Pravastatin—coronary artery disease	2.86e-05	0.000179	CcSEcCtD
Mirtazapine—Vomiting—Olmesartan—coronary artery disease	2.86e-05	0.000179	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.85e-05	0.000179	CcSEcCtD
Mirtazapine—Rash—Valsartan—coronary artery disease	2.85e-05	0.000179	CcSEcCtD
Mirtazapine—Dermatitis—Valsartan—coronary artery disease	2.85e-05	0.000179	CcSEcCtD
Mirtazapine—Nausea—Simvastatin—coronary artery disease	2.84e-05	0.000178	CcSEcCtD
Mirtazapine—Oedema—Lisinopril—coronary artery disease	2.84e-05	0.000178	CcSEcCtD
Mirtazapine—Pruritus—Captopril—coronary artery disease	2.84e-05	0.000178	CcSEcCtD
Mirtazapine—Rash—Olmesartan—coronary artery disease	2.84e-05	0.000178	CcSEcCtD
Mirtazapine—Insomnia—Ramipril—coronary artery disease	2.83e-05	0.000178	CcSEcCtD
Mirtazapine—Dermatitis—Olmesartan—coronary artery disease	2.83e-05	0.000178	CcSEcCtD
Mirtazapine—Headache—Valsartan—coronary artery disease	2.83e-05	0.000178	CcSEcCtD
Mirtazapine—Diarrhoea—Telmisartan—coronary artery disease	2.82e-05	0.000177	CcSEcCtD
Mirtazapine—Infection—Lisinopril—coronary artery disease	2.82e-05	0.000177	CcSEcCtD
Mirtazapine—Headache—Olmesartan—coronary artery disease	2.82e-05	0.000177	CcSEcCtD
Mirtazapine—Paraesthesia—Ramipril—coronary artery disease	2.81e-05	0.000176	CcSEcCtD
Mirtazapine—Shock—Lisinopril—coronary artery disease	2.8e-05	0.000175	CcSEcCtD
Mirtazapine—Asthenia—Perindopril—coronary artery disease	2.8e-05	0.000175	CcSEcCtD
Mirtazapine—Dyspnoea—Ramipril—coronary artery disease	2.79e-05	0.000175	CcSEcCtD
Mirtazapine—Vomiting—Niacin—coronary artery disease	2.79e-05	0.000175	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Timolol—coronary artery disease	2.79e-05	0.000175	CcSEcCtD
Mirtazapine—Hypersensitivity—Furosemide—coronary artery disease	2.79e-05	0.000175	CcSEcCtD
Mirtazapine—Somnolence—Ramipril—coronary artery disease	2.79e-05	0.000175	CcSEcCtD
Mirtazapine—Thrombocytopenia—Lisinopril—coronary artery disease	2.78e-05	0.000174	CcSEcCtD
Mirtazapine—Dizziness—Trandolapril—coronary artery disease	2.78e-05	0.000174	CcSEcCtD
Mirtazapine—Tachycardia—Lisinopril—coronary artery disease	2.77e-05	0.000174	CcSEcCtD
Mirtazapine—Insomnia—Timolol—coronary artery disease	2.77e-05	0.000174	CcSEcCtD
Mirtazapine—Rash—Niacin—coronary artery disease	2.77e-05	0.000174	CcSEcCtD
Mirtazapine—Dermatitis—Niacin—coronary artery disease	2.77e-05	0.000174	CcSEcCtD
Mirtazapine—Dizziness—Enalapril—coronary artery disease	2.77e-05	0.000174	CcSEcCtD
Mirtazapine—Skin disorder—Lisinopril—coronary artery disease	2.76e-05	0.000173	CcSEcCtD
Mirtazapine—Dyspepsia—Ramipril—coronary artery disease	2.76e-05	0.000173	CcSEcCtD
Mirtazapine—Pruritus—Perindopril—coronary artery disease	2.76e-05	0.000173	CcSEcCtD
Mirtazapine—Headache—Niacin—coronary artery disease	2.75e-05	0.000173	CcSEcCtD
Mirtazapine—Paraesthesia—Timolol—coronary artery disease	2.75e-05	0.000173	CcSEcCtD
Mirtazapine—Vomiting—Pravastatin—coronary artery disease	2.75e-05	0.000172	CcSEcCtD
Mirtazapine—Hyperhidrosis—Lisinopril—coronary artery disease	2.75e-05	0.000172	CcSEcCtD
Mirtazapine—Diarrhoea—Captopril—coronary artery disease	2.75e-05	0.000172	CcSEcCtD
Mirtazapine—Dyspnoea—Timolol—coronary artery disease	2.73e-05	0.000171	CcSEcCtD
Mirtazapine—Dizziness—Telmisartan—coronary artery disease	2.73e-05	0.000171	CcSEcCtD
Mirtazapine—Rash—Pravastatin—coronary artery disease	2.73e-05	0.000171	CcSEcCtD
Mirtazapine—Dermatitis—Pravastatin—coronary artery disease	2.72e-05	0.000171	CcSEcCtD
Mirtazapine—Decreased appetite—Ramipril—coronary artery disease	2.72e-05	0.000171	CcSEcCtD
Mirtazapine—Somnolence—Timolol—coronary artery disease	2.72e-05	0.000171	CcSEcCtD
Mirtazapine—Asthenia—Furosemide—coronary artery disease	2.72e-05	0.00017	CcSEcCtD
Mirtazapine—Headache—Pravastatin—coronary artery disease	2.71e-05	0.00017	CcSEcCtD
Mirtazapine—Anorexia—Lisinopril—coronary artery disease	2.71e-05	0.00017	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Ramipril—coronary artery disease	2.71e-05	0.00017	CcSEcCtD
Mirtazapine—Fatigue—Ramipril—coronary artery disease	2.7e-05	0.000169	CcSEcCtD
Mirtazapine—Dyspepsia—Timolol—coronary artery disease	2.7e-05	0.000169	CcSEcCtD
Mirtazapine—Hypersensitivity—Losartan—coronary artery disease	2.69e-05	0.000169	CcSEcCtD
Mirtazapine—Nausea—Valsartan—coronary artery disease	2.68e-05	0.000168	CcSEcCtD
Mirtazapine—Pruritus—Furosemide—coronary artery disease	2.68e-05	0.000168	CcSEcCtD
Mirtazapine—Constipation—Ramipril—coronary artery disease	2.68e-05	0.000168	CcSEcCtD
Mirtazapine—Nausea—Olmesartan—coronary artery disease	2.67e-05	0.000168	CcSEcCtD
Mirtazapine—Vomiting—Trandolapril—coronary artery disease	2.67e-05	0.000168	CcSEcCtD
Mirtazapine—Diarrhoea—Perindopril—coronary artery disease	2.67e-05	0.000167	CcSEcCtD
Mirtazapine—Decreased appetite—Timolol—coronary artery disease	2.66e-05	0.000167	CcSEcCtD
Mirtazapine—Vomiting—Enalapril—coronary artery disease	2.66e-05	0.000167	CcSEcCtD
Mirtazapine—Hypotension—Lisinopril—coronary artery disease	2.66e-05	0.000167	CcSEcCtD
Mirtazapine—Dizziness—Captopril—coronary artery disease	2.65e-05	0.000166	CcSEcCtD
Mirtazapine—Rash—Trandolapril—coronary artery disease	2.65e-05	0.000166	CcSEcCtD
Mirtazapine—Dermatitis—Trandolapril—coronary artery disease	2.65e-05	0.000166	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Timolol—coronary artery disease	2.64e-05	0.000166	CcSEcCtD
Mirtazapine—Fatigue—Timolol—coronary artery disease	2.64e-05	0.000166	CcSEcCtD
Mirtazapine—Rash—Enalapril—coronary artery disease	2.64e-05	0.000165	CcSEcCtD
Mirtazapine—Dermatitis—Enalapril—coronary artery disease	2.64e-05	0.000165	CcSEcCtD
Mirtazapine—Headache—Trandolapril—coronary artery disease	2.63e-05	0.000165	CcSEcCtD
Mirtazapine—Vomiting—Telmisartan—coronary artery disease	2.62e-05	0.000165	CcSEcCtD
Mirtazapine—Asthenia—Losartan—coronary artery disease	2.62e-05	0.000164	CcSEcCtD
Mirtazapine—Headache—Enalapril—coronary artery disease	2.62e-05	0.000164	CcSEcCtD
Mirtazapine—Pain—Timolol—coronary artery disease	2.62e-05	0.000164	CcSEcCtD
Mirtazapine—Nausea—Niacin—coronary artery disease	2.61e-05	0.000164	CcSEcCtD
Mirtazapine—Rash—Telmisartan—coronary artery disease	2.6e-05	0.000163	CcSEcCtD
Mirtazapine—Dermatitis—Telmisartan—coronary artery disease	2.6e-05	0.000163	CcSEcCtD
Mirtazapine—Diarrhoea—Furosemide—coronary artery disease	2.59e-05	0.000163	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.59e-05	0.000162	CcSEcCtD
Mirtazapine—Pruritus—Losartan—coronary artery disease	2.59e-05	0.000162	CcSEcCtD
Mirtazapine—Headache—Telmisartan—coronary artery disease	2.58e-05	0.000162	CcSEcCtD
Mirtazapine—Feeling abnormal—Ramipril—coronary artery disease	2.58e-05	0.000162	CcSEcCtD
Mirtazapine—Dizziness—Perindopril—coronary artery disease	2.58e-05	0.000162	CcSEcCtD
Mirtazapine—Insomnia—Lisinopril—coronary artery disease	2.57e-05	0.000161	CcSEcCtD
Mirtazapine—Nausea—Pravastatin—coronary artery disease	2.57e-05	0.000161	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Ramipril—coronary artery disease	2.56e-05	0.000161	CcSEcCtD
Mirtazapine—Paraesthesia—Lisinopril—coronary artery disease	2.55e-05	0.00016	CcSEcCtD
Mirtazapine—Vomiting—Captopril—coronary artery disease	2.55e-05	0.00016	CcSEcCtD
Mirtazapine—Dyspnoea—Lisinopril—coronary artery disease	2.53e-05	0.000159	CcSEcCtD
Mirtazapine—Rash—Captopril—coronary artery disease	2.53e-05	0.000159	CcSEcCtD
Mirtazapine—Dermatitis—Captopril—coronary artery disease	2.53e-05	0.000159	CcSEcCtD
Mirtazapine—Somnolence—Lisinopril—coronary artery disease	2.53e-05	0.000158	CcSEcCtD
Mirtazapine—Feeling abnormal—Timolol—coronary artery disease	2.52e-05	0.000158	CcSEcCtD
Mirtazapine—Headache—Captopril—coronary artery disease	2.51e-05	0.000158	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Timolol—coronary artery disease	2.5e-05	0.000157	CcSEcCtD
Mirtazapine—Dizziness—Furosemide—coronary artery disease	2.5e-05	0.000157	CcSEcCtD
Mirtazapine—Dyspepsia—Lisinopril—coronary artery disease	2.5e-05	0.000157	CcSEcCtD
Mirtazapine—Diarrhoea—Losartan—coronary artery disease	2.5e-05	0.000157	CcSEcCtD
Mirtazapine—Nausea—Trandolapril—coronary artery disease	2.49e-05	0.000156	CcSEcCtD
Mirtazapine—Urticaria—Ramipril—coronary artery disease	2.49e-05	0.000156	CcSEcCtD
Mirtazapine—Nausea—Enalapril—coronary artery disease	2.48e-05	0.000156	CcSEcCtD
Mirtazapine—Vomiting—Perindopril—coronary artery disease	2.48e-05	0.000155	CcSEcCtD
Mirtazapine—Abdominal pain—Ramipril—coronary artery disease	2.48e-05	0.000155	CcSEcCtD
Mirtazapine—Body temperature increased—Ramipril—coronary artery disease	2.48e-05	0.000155	CcSEcCtD
Mirtazapine—Decreased appetite—Lisinopril—coronary artery disease	2.47e-05	0.000155	CcSEcCtD
Mirtazapine—Rash—Perindopril—coronary artery disease	2.46e-05	0.000154	CcSEcCtD
Mirtazapine—Dermatitis—Perindopril—coronary artery disease	2.45e-05	0.000154	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.45e-05	0.000154	CcSEcCtD
Mirtazapine—Nausea—Telmisartan—coronary artery disease	2.45e-05	0.000154	CcSEcCtD
Mirtazapine—Fatigue—Lisinopril—coronary artery disease	2.45e-05	0.000154	CcSEcCtD
Mirtazapine—Headache—Perindopril—coronary artery disease	2.44e-05	0.000153	CcSEcCtD
Mirtazapine—Urticaria—Timolol—coronary artery disease	2.43e-05	0.000153	CcSEcCtD
Mirtazapine—Pain—Lisinopril—coronary artery disease	2.43e-05	0.000152	CcSEcCtD
Mirtazapine—Constipation—Lisinopril—coronary artery disease	2.43e-05	0.000152	CcSEcCtD
Mirtazapine—Abdominal pain—Timolol—coronary artery disease	2.42e-05	0.000152	CcSEcCtD
Mirtazapine—Body temperature increased—Timolol—coronary artery disease	2.42e-05	0.000152	CcSEcCtD
Mirtazapine—Dizziness—Losartan—coronary artery disease	2.42e-05	0.000152	CcSEcCtD
Mirtazapine—Vomiting—Furosemide—coronary artery disease	2.41e-05	0.000151	CcSEcCtD
Mirtazapine—Rash—Furosemide—coronary artery disease	2.39e-05	0.00015	CcSEcCtD
Mirtazapine—Dermatitis—Furosemide—coronary artery disease	2.39e-05	0.00015	CcSEcCtD
Mirtazapine—Nausea—Captopril—coronary artery disease	2.38e-05	0.000149	CcSEcCtD
Mirtazapine—Headache—Furosemide—coronary artery disease	2.37e-05	0.000149	CcSEcCtD
Mirtazapine—Feeling abnormal—Lisinopril—coronary artery disease	2.34e-05	0.000147	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Lisinopril—coronary artery disease	2.32e-05	0.000146	CcSEcCtD
Mirtazapine—Vomiting—Losartan—coronary artery disease	2.32e-05	0.000146	CcSEcCtD
Mirtazapine—Nausea—Perindopril—coronary artery disease	2.31e-05	0.000145	CcSEcCtD
Mirtazapine—Hypersensitivity—Ramipril—coronary artery disease	2.31e-05	0.000145	CcSEcCtD
Mirtazapine—Rash—Losartan—coronary artery disease	2.3e-05	0.000145	CcSEcCtD
Mirtazapine—Dermatitis—Losartan—coronary artery disease	2.3e-05	0.000144	CcSEcCtD
Mirtazapine—Headache—Losartan—coronary artery disease	2.29e-05	0.000144	CcSEcCtD
Mirtazapine—Urticaria—Lisinopril—coronary artery disease	2.26e-05	0.000142	CcSEcCtD
Mirtazapine—Hypersensitivity—Timolol—coronary artery disease	2.26e-05	0.000142	CcSEcCtD
Mirtazapine—Nausea—Furosemide—coronary artery disease	2.25e-05	0.000141	CcSEcCtD
Mirtazapine—Asthenia—Ramipril—coronary artery disease	2.25e-05	0.000141	CcSEcCtD
Mirtazapine—Body temperature increased—Lisinopril—coronary artery disease	2.25e-05	0.000141	CcSEcCtD
Mirtazapine—Abdominal pain—Lisinopril—coronary artery disease	2.25e-05	0.000141	CcSEcCtD
Mirtazapine—Pruritus—Ramipril—coronary artery disease	2.22e-05	0.000139	CcSEcCtD
Mirtazapine—Asthenia—Timolol—coronary artery disease	2.2e-05	0.000138	CcSEcCtD
Mirtazapine—Nausea—Losartan—coronary artery disease	2.17e-05	0.000136	CcSEcCtD
Mirtazapine—Pruritus—Timolol—coronary artery disease	2.17e-05	0.000136	CcSEcCtD
Mirtazapine—Diarrhoea—Ramipril—coronary artery disease	2.14e-05	0.000134	CcSEcCtD
Mirtazapine—Diarrhoea—Timolol—coronary artery disease	2.1e-05	0.000131	CcSEcCtD
Mirtazapine—Hypersensitivity—Lisinopril—coronary artery disease	2.09e-05	0.000131	CcSEcCtD
Mirtazapine—Dizziness—Ramipril—coronary artery disease	2.07e-05	0.00013	CcSEcCtD
Mirtazapine—Asthenia—Lisinopril—coronary artery disease	2.04e-05	0.000128	CcSEcCtD
Mirtazapine—Dizziness—Timolol—coronary artery disease	2.03e-05	0.000127	CcSEcCtD
Mirtazapine—Pruritus—Lisinopril—coronary artery disease	2.01e-05	0.000126	CcSEcCtD
Mirtazapine—Vomiting—Ramipril—coronary artery disease	1.99e-05	0.000125	CcSEcCtD
Mirtazapine—Rash—Ramipril—coronary artery disease	1.98e-05	0.000124	CcSEcCtD
Mirtazapine—Dermatitis—Ramipril—coronary artery disease	1.97e-05	0.000124	CcSEcCtD
Mirtazapine—Headache—Ramipril—coronary artery disease	1.96e-05	0.000123	CcSEcCtD
Mirtazapine—Vomiting—Timolol—coronary artery disease	1.95e-05	0.000122	CcSEcCtD
Mirtazapine—Diarrhoea—Lisinopril—coronary artery disease	1.94e-05	0.000122	CcSEcCtD
Mirtazapine—Rash—Timolol—coronary artery disease	1.93e-05	0.000121	CcSEcCtD
Mirtazapine—Dermatitis—Timolol—coronary artery disease	1.93e-05	0.000121	CcSEcCtD
Mirtazapine—Headache—Timolol—coronary artery disease	1.92e-05	0.00012	CcSEcCtD
Mirtazapine—Dizziness—Lisinopril—coronary artery disease	1.88e-05	0.000118	CcSEcCtD
Mirtazapine—Nausea—Ramipril—coronary artery disease	1.86e-05	0.000117	CcSEcCtD
Mirtazapine—Nausea—Timolol—coronary artery disease	1.82e-05	0.000114	CcSEcCtD
Mirtazapine—Vomiting—Lisinopril—coronary artery disease	1.81e-05	0.000113	CcSEcCtD
Mirtazapine—Rash—Lisinopril—coronary artery disease	1.79e-05	0.000112	CcSEcCtD
Mirtazapine—Dermatitis—Lisinopril—coronary artery disease	1.79e-05	0.000112	CcSEcCtD
Mirtazapine—Headache—Lisinopril—coronary artery disease	1.78e-05	0.000112	CcSEcCtD
Mirtazapine—Nausea—Lisinopril—coronary artery disease	1.69e-05	0.000106	CcSEcCtD
Mirtazapine—ADRB1—Signaling by GPCR—IL6—coronary artery disease	9.62e-07	9.19e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	9.62e-07	9.19e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	9.59e-07	9.16e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—MTHFR—coronary artery disease	9.58e-07	9.15e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NOS3—coronary artery disease	9.58e-07	9.15e-06	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	9.56e-07	9.13e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—FGF2—coronary artery disease	9.56e-07	9.13e-06	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MAPK1—coronary artery disease	9.55e-07	9.12e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—FGF2—coronary artery disease	9.54e-07	9.11e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—MTHFR—coronary artery disease	9.5e-07	9.07e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CASP3—coronary artery disease	9.47e-07	9.05e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PPARG—coronary artery disease	9.46e-07	9.04e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	9.46e-07	9.03e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOB—coronary artery disease	9.44e-07	9.02e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCND1—coronary artery disease	9.43e-07	9e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	9.43e-07	9e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	9.41e-07	8.99e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL6—coronary artery disease	9.41e-07	8.99e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NOS3—coronary artery disease	9.41e-07	8.98e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—coronary artery disease	9.38e-07	8.96e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	9.36e-07	8.94e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	9.36e-07	8.94e-06	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	9.35e-07	8.93e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—POMC—coronary artery disease	9.33e-07	8.91e-06	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TGFB1—coronary artery disease	9.32e-07	8.9e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—JAK2—coronary artery disease	9.31e-07	8.89e-06	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	9.3e-07	8.88e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CASP3—coronary artery disease	9.26e-07	8.84e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	9.23e-07	8.81e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCND1—coronary artery disease	9.22e-07	8.8e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	9.21e-07	8.8e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL6—coronary artery disease	9.2e-07	8.79e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GSTM1—coronary artery disease	9.18e-07	8.77e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	9.16e-07	8.75e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	9.16e-07	8.74e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MMP9—coronary artery disease	9.15e-07	8.74e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PLCB1—coronary artery disease	9.15e-07	8.73e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—JAK2—coronary artery disease	9.14e-07	8.73e-06	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MAPK1—coronary artery disease	9.14e-07	8.73e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	9.12e-07	8.71e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AGT—coronary artery disease	9.1e-07	8.69e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	9.05e-07	8.64e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AGT—coronary artery disease	9.02e-07	8.62e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—VEGFA—coronary artery disease	9.02e-07	8.61e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCND1—coronary artery disease	9.02e-07	8.61e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—LPL—coronary artery disease	9.01e-07	8.61e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	8.99e-07	8.59e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	8.98e-07	8.58e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	8.98e-07	8.57e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	8.97e-07	8.56e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	8.97e-07	8.56e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	8.96e-07	8.56e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	8.96e-07	8.55e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MMP9—coronary artery disease	8.95e-07	8.55e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—APOE—coronary artery disease	8.92e-07	8.52e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	8.9e-07	8.5e-06	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	8.9e-07	8.49e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	8.88e-07	8.48e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ABCA1—coronary artery disease	8.87e-07	8.47e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—APOE—coronary artery disease	8.84e-07	8.44e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—APOA1—coronary artery disease	8.82e-07	8.42e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GPX1—coronary artery disease	8.8e-07	8.4e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	8.79e-07	8.39e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MMP9—coronary artery disease	8.75e-07	8.36e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—APOA1—coronary artery disease	8.74e-07	8.35e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	8.72e-07	8.33e-06	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	8.72e-07	8.33e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	8.71e-07	8.32e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	8.69e-07	8.3e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	8.68e-07	8.29e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GOT1—coronary artery disease	8.59e-07	8.2e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GGT1—coronary artery disease	8.59e-07	8.2e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	8.57e-07	8.19e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CD36—coronary artery disease	8.57e-07	8.18e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ALB—coronary artery disease	8.51e-07	8.13e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	8.5e-07	8.11e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	8.49e-07	8.11e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	8.47e-07	8.09e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	8.46e-07	8.08e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	8.45e-07	8.06e-06	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	8.42e-07	8.04e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.37e-07	7.99e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	8.36e-07	7.98e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	8.34e-07	7.97e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	8.33e-07	7.96e-06	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	8.28e-07	7.91e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TGFB1—coronary artery disease	8.28e-07	7.9e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	8.22e-07	7.85e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	8.21e-07	7.84e-06	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	8.21e-07	7.84e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	8.19e-07	7.82e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	8.17e-07	7.8e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—NOS3—coronary artery disease	8.14e-07	7.77e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CASP3—coronary artery disease	8.13e-07	7.77e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MAPK1—coronary artery disease	8.12e-07	7.75e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—MTHFR—coronary artery disease	8.12e-07	7.75e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—coronary artery disease	8.08e-07	7.72e-06	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	8.08e-07	7.71e-06	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	8.06e-07	7.7e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	8.04e-07	7.68e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	8e-07	7.64e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—coronary artery disease	7.98e-07	7.62e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	7.95e-07	7.59e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—coronary artery disease	7.93e-07	7.58e-06	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	7.93e-07	7.57e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—coronary artery disease	7.92e-07	7.56e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	7.91e-07	7.55e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	7.86e-07	7.51e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	7.84e-07	7.48e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	7.82e-07	7.47e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	7.79e-07	7.44e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	7.78e-07	7.43e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—coronary artery disease	7.77e-07	7.42e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARG—coronary artery disease	7.77e-07	7.42e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTP1—coronary artery disease	7.71e-07	7.37e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AGT—coronary artery disease	7.71e-07	7.36e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARG—coronary artery disease	7.7e-07	7.35e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—coronary artery disease	7.69e-07	7.34e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—POMC—coronary artery disease	7.66e-07	7.32e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	7.64e-07	7.3e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	7.63e-07	7.28e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—HMOX1—coronary artery disease	7.61e-07	7.26e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	7.61e-07	7.26e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	7.61e-07	7.26e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—POMC—coronary artery disease	7.6e-07	7.25e-06	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	7.57e-07	7.23e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	7.56e-07	7.22e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOE—coronary artery disease	7.56e-07	7.22e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—coronary artery disease	7.55e-07	7.21e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	7.54e-07	7.2e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CAT—coronary artery disease	7.51e-07	7.17e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOA1—coronary artery disease	7.47e-07	7.13e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	7.45e-07	7.12e-06	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—coronary artery disease	7.45e-07	7.12e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—coronary artery disease	7.44e-07	7.11e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	7.4e-07	7.07e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	7.4e-07	7.06e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	7.38e-07	7.05e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	7.35e-07	7.02e-06	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—coronary artery disease	7.34e-07	7e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	7.33e-07	7e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	7.32e-07	6.99e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOB—coronary artery disease	7.29e-07	6.96e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	7.28e-07	6.95e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	7.24e-07	6.91e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	7.23e-07	6.91e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	7.21e-07	6.89e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	7.18e-07	6.86e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	7.18e-07	6.85e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.15e-07	6.83e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—coronary artery disease	7.1e-07	6.78e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTM1—coronary artery disease	7.09e-07	6.77e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	7.09e-07	6.77e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	7.07e-07	6.76e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	7.04e-07	6.73e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	7.04e-07	6.72e-06	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—coronary artery disease	7.02e-07	6.71e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—coronary artery disease	6.99e-07	6.67e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	6.98e-07	6.67e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—LPL—coronary artery disease	6.96e-07	6.64e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—coronary artery disease	6.93e-07	6.61e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	6.9e-07	6.59e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	6.88e-07	6.57e-06	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—coronary artery disease	6.87e-07	6.56e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	6.85e-07	6.54e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	6.79e-07	6.48e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GPX1—coronary artery disease	6.79e-07	6.48e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	6.78e-07	6.47e-06	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—coronary artery disease	6.77e-07	6.46e-06	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—coronary artery disease	6.7e-07	6.4e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—NOS3—coronary artery disease	6.68e-07	6.38e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	6.67e-07	6.37e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	6.65e-07	6.35e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—NOS3—coronary artery disease	6.62e-07	6.33e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CD36—coronary artery disease	6.61e-07	6.31e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARG—coronary artery disease	6.58e-07	6.28e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	6.53e-07	6.23e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—POMC—coronary artery disease	6.49e-07	6.2e-06	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—coronary artery disease	6.48e-07	6.19e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	6.42e-07	6.13e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	6.33e-07	6.05e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	6.28e-07	6e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—MTHFR—coronary artery disease	6.26e-07	5.98e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—coronary artery disease	6.24e-07	5.96e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	6.23e-07	5.95e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	6.22e-07	5.94e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	6.21e-07	5.93e-06	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—coronary artery disease	6.18e-07	5.91e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	6.18e-07	5.9e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	6.14e-07	5.86e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	6.11e-07	5.84e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—coronary artery disease	6.11e-07	5.84e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	6.11e-07	5.83e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	6.1e-07	5.83e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	6.1e-07	5.82e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—coronary artery disease	6.06e-07	5.79e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	5.98e-07	5.71e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AGT—coronary artery disease	5.95e-07	5.68e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	5.94e-07	5.67e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—coronary artery disease	5.92e-07	5.65e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOE—coronary artery disease	5.83e-07	5.57e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—coronary artery disease	5.8e-07	5.54e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	5.77e-07	5.51e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOA1—coronary artery disease	5.76e-07	5.5e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—coronary artery disease	5.75e-07	5.49e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—coronary artery disease	5.68e-07	5.43e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	5.67e-07	5.41e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—NOS3—coronary artery disease	5.66e-07	5.41e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	5.56e-07	5.31e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—coronary artery disease	5.56e-07	5.31e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—coronary artery disease	5.44e-07	5.19e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—coronary artery disease	5.41e-07	5.16e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	5.39e-07	5.15e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	5.3e-07	5.06e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	5.29e-07	5.05e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—coronary artery disease	5.26e-07	5.02e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—coronary artery disease	5.24e-07	5.01e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	5.19e-07	4.96e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—coronary artery disease	5.18e-07	4.94e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—coronary artery disease	5.13e-07	4.9e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARG—coronary artery disease	5.08e-07	4.85e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—coronary artery disease	5.02e-07	4.79e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—POMC—coronary artery disease	5.01e-07	4.78e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	4.99e-07	4.76e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	4.85e-07	4.63e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	4.83e-07	4.61e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—coronary artery disease	4.77e-07	4.56e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—coronary artery disease	4.71e-07	4.5e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—coronary artery disease	4.7e-07	4.48e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—coronary artery disease	4.69e-07	4.47e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	4.6e-07	4.39e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—coronary artery disease	4.58e-07	4.37e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—coronary artery disease	4.57e-07	4.36e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—coronary artery disease	4.4e-07	4.2e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NOS3—coronary artery disease	4.37e-07	4.17e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	4.33e-07	4.14e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—coronary artery disease	4.32e-07	4.13e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	4.27e-07	4.08e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	4.24e-07	4.05e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—coronary artery disease	4e-07	3.82e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	3.94e-07	3.76e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	3.76e-07	3.59e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—coronary artery disease	3.74e-07	3.57e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	3.73e-07	3.56e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	3.19e-07	3.04e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—coronary artery disease	3.07e-07	2.93e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—coronary artery disease	3.05e-07	2.91e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—coronary artery disease	2.6e-07	2.48e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.46e-07	2.35e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—coronary artery disease	2.01e-07	1.92e-06	CbGpPWpGaD
